CautionCyclophosphamide

Cyclophosphamide

Alkylating agent

Contraindicated — reserved for organ- or life-threatening flare only.

OralIV

First-line for

  • Severe/organ-threatening lupus nephritis or vasculitis unresponsive to other agents — specialist-led only

Mechanism

DNA cross-linking alkylating agent → cytotoxic to rapidly dividing cells, including lymphocytes.

Cyclophosphamide pregnancy rule

  • Stop ≥3 months before planned conception (both partners)
  • Dose- and age-dependent infertility — counsel on fertility preservation first
  • Teratogenic — avoid in all trimesters

Dosing

Non-pregnant (severe flare)
Specialist protocol — IV pulses, e.g. Eurolupus regimen

Contraindications

  • AbsolutePregnancy — teratogenic
  • AbsoluteBreastfeeding

Side effects

  • Haemorrhagic cystitis
  • Marrow suppression
  • Infertility (dose/age-dependent, can be irreversible)
  • ↑ malignancy risk long-term

Fetal & maternal notes

  • Only ever used in pregnancy for genuinely organ- or life-threatening maternal disease where no alternative exists — MDT/specialist decision, not routine care.

Key interactions

  • Allopurinol

    Avoid

    ↑ myelosuppression

Clinical pearls

  • 💡 Counsel on fertility preservation (e.g. GnRH agonist co-treatment, egg/embryo freezing) before use in women of reproductive age when time allows.

Content last reviewed: REPLACE_ME (e.g. 2026-07) · Sources: Rheumatology Secrets 5th ed. Table 78.2

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.